Search
Amphastar Pharmaceuticals Inc
AMPHAdd to Watchlist
19.940USD
-0.440-2.16%
Close 07-31 16:00（ET）Quotes delayed by 15 min
879.21MMarket Cap
11.66P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Amphastar Pharmaceuticals Inc is 6.29, ranking 130 out of 155 in the Pharmaceuticals industry. The average price target is 31.00, with a high of 38.00 and a low of 25.00.
Analyst Rating
Based on
7
analysts
Hold
Current Rating
22.000
Target Price
+10.33%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Amphastar Pharmaceuticals Inc
AMPH
7
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
32
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Amphastar Pharmaceuticals Inc's expected revenue for the next quarter?
Amphastar Pharmaceuticals Inc's expected revenue is 182.06M.
What is Amphastar Pharmaceuticals Inc's price target?
Analysts forecast that Amphastar Pharmaceuticals Inc's price target is USD 31.00, with the highest forecast at USD 38.00 and the lowest forecast at USD 25.00.
How have Amphastar Pharmaceuticals IncAMPH's recent earnings per share performed?
The market expectation was USD 0.14, while Amphastar Pharmaceuticals IncAMPH's earnings per share (EPS) for the previous quarter was USD 0.53. EPS for the next quarter is expected at USD 0.62.
What is the analyst rating for Amphastar Pharmaceuticals Inc?
Based on the ratings of Amphastar Pharmaceuticals Inc's stock from 7 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.